Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5863-78-5

Post Buying Request

5863-78-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5863-78-5 Usage

General Description

(E)-3-(4-Methoxystyryl)pyridine is a chemical compound with the molecular formula C13H11NO. It is a member of the styrylpyridine family, which are often used as dyes, fluorescent labels, and chemical intermediates. This specific compound is known for its potential applications in organic electronics, particularly as a material for organic light-emitting diodes (OLEDs) due to its photophysical properties. It is a yellow solid at room temperature and is insoluble in water, but soluble in organic solvents. (E)-3-(4-Methoxystyryl)pyridine is currently being researched for its potential uses in optoelectronic devices and as a fluorescent probe for biological imaging.

Check Digit Verification of cas no

The CAS Registry Mumber 5863-78-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,8,6 and 3 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 5863-78:
(6*5)+(5*8)+(4*6)+(3*3)+(2*7)+(1*8)=125
125 % 10 = 5
So 5863-78-5 is a valid CAS Registry Number.

5863-78-5Relevant articles and documents

A new insight into the push-pull effect of substituents via the stilbene-like model compounds

Cao, Chaotun,Cao, Chenzhong,Zeng, Zhao

, (2022/02/01)

In this paper, authors report on 1-pyridyl-2-arylethenes, 1-furyl-2-arylethylenes, 1,2-diphenylpropylenes and substituted cinnamyl anilines as stilbene-like model compounds to investigate the factors dominating the push-pull effect of substituents via usi

THERAPEUTIC AGENTS FOR SKIN DISEASES AND CONDITIONS

-

Page/Page column 37; 48-49; 54, (2015/06/18)

The present invention relates to method(s) of treating a subject afflicted with a skin disease or condition, the method comprising administering to the subject or patient in need a composition comprising a therapeutically effective amount of a substituted cis or trans- stilbene or a stilbene hybrid. A method of treating or reducing the likelihood of a skin disease or condition in a patient is an additional embodiment of the present invention. Preferred pharmaceutical compositions of the invention include nanoemulsions comprising a therapeutically effective amount of a substituted cis or trans-stilbene or stilbene hybrid and at least one antibiotic.

Mechanistic studies on the Pd-catalyzed vinylation of aryl halides with vinylalkoxysilanes in water: The effect of the solvent and NaOH promoter

Gordillo, Alvaro,Ortuno, Manuel A.,Lopez-Mardomingo, Carmen,Lledos, Agusti,Ujaque, Gregori,De Jesus, Ernesto

supporting information, p. 13749 - 13763 (2013/10/01)

The mechanism of the Pd-catalyzed vinylation of aryl halides with vinylalkoxysilanes in water has been studied using different catalytic precursors. The NaOH promoter converts the initial vinylalkoxysilane into a highly reactive water-soluble vinylsilanolate species. Similarly, deuterium-labeling experiments have shown that, irrespective of the catalytic precursor used, vinylation occurs exclusively at the CH vinylic functionality via a Heck reaction and not at the C-Si bond via a Hiyama cross-coupling. The involvement of a Heck mechanism is interpreted in terms of the reduced nucleophilicity of the base in water, which disfavors the transmetalation step. The Heck product (β-silylvinylarene) undergoes partial desilylation, with formation of a vinylarene, by three different routes: (a) hydrolytic desilylation by the aqueous solvent (only at high temperature); (b) transmetalation of the silyl olefin on the PdH Heck intermediate followed by reductive elimination of vinylarene; (c) reinsertion of the silyl olefin into the PdH bond of the Heck intermediate followed by β-Si syn-elimination. Both the Hiyama and Heck catalytic cycles and desilylation mechanisms b and c have been computationally evaluated for the [Pd(en)Cl2] precursor in water as solvent. The calculated Gibbs energy barriers support the reinsertion route proposed on the basis of the experimental results.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5863-78-5